Immunic, Inc. (IMUX) Operating income 2016–2025
Immunic, Inc. (IMUX) annual operating income history from SEC filings — each fiscal year as reported.
-$103.2MFY2025 · since FY2016: -$41.3M → -$103.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$103.2M | -5.3% |
| FY2024 | -$98.1M | +1.2% |
| FY2023 | -$99.2M | +17.0% |
| FY2022 | -$119.5M | -30.4% |
| FY2021 | -$91.7M | -87.2% |
| FY2020 | -$49.0M | -32.2% |
| FY2019 | -$37.0M | -208.7% |
| FY2018 | -$12.0M | +77.2% |
| FY2017 | -$52.7M | -27.6% |
| FY2016 | -$41.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice